Filing Details
- Accession Number:
- 0001213900-22-013940
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-21 20:03:36
- Reporting Period:
- 2022-03-17
- Accepted Time:
- 2022-03-21 20:03:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1779020 | Danimer Scientific Inc. | DNMR | Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821) | 841924518 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1836749 | Scott Tuten | C/O Danimer Scientific, Inc. 140 Industrial Boulevard Bainbridge GA 39817 | Chief Marketing Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock ("Common Stock") | Acquisiton | 2022-03-17 | 10,000 | $3.28 | 514,136 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-17 | 10,000 | $4.50 | 504,136 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to purchase) | Disposition | 2022-03-17 | 10,000 | $0.00 | 10,000 | $3.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 281,256 | 2026-11-14 | No | 4 | M | Direct |
Footnotes
- Includes 348,744 restricted shares of the Common Stock granted under a previously disclosed restricted stock award.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Tuten on June 25, 2021. The Reporting Person exercised no discretion with respect to the sale. Proceeds from the sale were used to pay the exercise price of stock options, pursuant to a broker-assisted cashless exercise, and applicable withholding taxes.
- The sale of shares of Common Stock was executed in multiple trades at prices ranging from $4.50 to $4.505. The price reported above reflects the volume-weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- The options are fully vested and currently exercisable.
Billionaire Hedge Funds
